Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

50%(2 trials)

Terminated

1(14%)

Phase Distribution

Ph not_applicable

29%

Ph phase_2

14%

Ph phase_3

14%

Ph phase_4

14%

Ph phase_1

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

2(28.6%)

Phase 2Efficacy & side effects

1(14.3%)

Phase 3Large-scale testing

1(14.3%)

Phase 4Post-market surveillance

1(14.3%)

N/ANon-phased studies

2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(1)

Other(1)

Detailed Status

Completed4

Not yet recruiting1

unknown1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (28.6%)

Phase 21 (14.3%)

Phase 31 (14.3%)

Phase 41 (14.3%)

N/A2 (28.6%)

Trials by Status

completed457%

not_yet_recruiting114%

unknown114%

terminated114%

Recent Activity

0 active trials

Showing 5 of 7

not_yet_recruitingphase_3

A Phase 3 Study of HS-20094 in Patients With T2DM

NCT07156539

completedphase_2

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

NCT05254418

completedphase_1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus

NCT05516966

terminatedphase_4

Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

NCT03743025

unknownnot_applicable

The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity

NCT06331286

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT07156539Phase 3

A Phase 3 Study of HS-20094 in Patients With T2DM

Not Yet Recruiting

NCT05254418Phase 2

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

Completed

NCT05516966Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus

Completed

NCT03743025Phase 4

Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

Terminated

NCT06331286Not Applicable

The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity

Unknown

NCT06182891Not Applicable

Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy

Completed

NCT05459285Phase 1

A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7